Chemoinformaics analysis of N-Methoxy-N-methylacetamide
| Molecular Weight | 103.121 | nRot | 1 |
| Heavy Atom Molecular Weight | 94.049 | nRig | 1 |
| Exact Molecular Weight | 103.063 | nRing | 0 |
| Solubility: LogS | 0.817 | nHRing | 0 |
| Solubility: LogP | -0.342 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 15.3851 |
| nHD | 0 | BPOL | 12.2029 |
| QED | 0.438 |
| Synth | 2.816 |
| Natural Product Likeliness | -0.849 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.126 |
| HIA | 0.03 |
| CACO-2 | -4.307 |
| MDCK | 0.0000345 |
| BBB | 0.768 |
| PPB | 0.0754825 |
| VDSS | 0.813 |
| FU | 0.872962 |
| CYP1A2-inh | 0.02 |
| CYP1A2-sub | 0.819 |
| CYP2c19-inh | 0.023 |
| CYP2c19-sub | 0.589 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.232 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.247 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.263 |
| CL | 6.804 |
| T12 | 0.821 |
| hERG | 0.008 |
| Ames | 0.684 |
| ROA | 0.16 |
| SkinSen | 0.247 |
| Carcinogencity | 0.904 |
| EI | 0.988 |
| Respiratory | 0.078 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.943874 |